Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,254 | 348 | 88.7% |
| Travel and Lodging | $704.58 | 1 | 10.0% |
| Education | $92.86 | 2 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,674 | 138 | $0 (2024) |
| Veran Medical Technologies, Inc. | $986.52 | 3 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $904.22 | 33 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $717.48 | 39 | $0 (2024) |
| Covidien LP | $342.84 | 3 | $0 (2020) |
| Mylan Specialty L.P. | $260.18 | 15 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $229.42 | 20 | $0 (2020) |
| Actelion Pharmaceuticals US, Inc. | $194.64 | 12 | $0 (2023) |
| Genentech USA, Inc. | $188.85 | 6 | $0 (2020) |
| Grifols USA, LLC | $169.71 | 11 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $548.60 | 32 | GlaxoSmithKline, LLC. ($201.01) |
| 2023 | $717.41 | 36 | GlaxoSmithKline, LLC. ($384.45) |
| 2022 | $811.09 | 47 | GlaxoSmithKline, LLC. ($156.03) |
| 2021 | $773.29 | 44 | AstraZeneca Pharmaceuticals LP ($209.66) |
| 2020 | $799.42 | 38 | GlaxoSmithKline, LLC. ($166.97) |
| 2019 | $1,195 | 73 | GlaxoSmithKline, LLC. ($272.26) |
| 2018 | $636.75 | 46 | GlaxoSmithKline, LLC. ($174.54) |
| 2017 | $1,570 | 35 | Veran Medical Technologies, Inc. ($860.26) |
All Payment Transactions
351 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: RESPIRATORY | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $1.74 | General |
| Category: RESPIRATORY | ||||||
| 11/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Immunology | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: RESPIRATORY | ||||||
| 10/29/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.52 | General |
| Category: RESPIRATORY | ||||||
| 09/17/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $21.37 | General |
| 09/16/2024 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Education | In-kind items and services | $74.99 | General |
| Category: Immunology | ||||||
| 09/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.63 | General |
| Category: Immunology | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Respiratory | ||||||
| 09/11/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $15.11 | General |
| Category: HFCWO | ||||||
| 09/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: RESPIRATORY | ||||||
| 09/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $0.90 | General |
| Category: RESPIRATORY | ||||||
| 08/27/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: RESPIRATORY | ||||||
| 08/27/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $0.97 | General |
| Category: RESPIRATORY | ||||||
| 08/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: RESPIRATORY | ||||||
| 08/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: IMMUNOLOGY | ||||||
| 07/31/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Immunology | ||||||
| 07/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: Immunology | ||||||
| 06/26/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $12.79 | General |
| Category: HFCWO | ||||||
| 06/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: RESPIRATORY | ||||||
| 05/07/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: IMMUNOLOGY | ||||||
| 04/17/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: IMMUNOLOGY | ||||||
| 04/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 684 | 1,204 | $258,662 | $110,159 |
| 2022 | 10 | 743 | 1,149 | $227,599 | $94,983 |
| 2021 | 10 | 765 | 1,274 | $281,050 | $120,342 |
| 2020 | 12 | 790 | 1,349 | $286,675 | $120,831 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 86 | 230 | $99,360 | $37,736 | 38.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 128 | 320 | $58,240 | $29,188 | 50.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 105 | 180 | $32,400 | $14,912 | 46.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 110 | 217 | $27,559 | $12,782 | 46.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 85 | 87 | $30,711 | $11,556 | 37.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $7,020 | $2,942 | 41.9% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 48 | 48 | $1,344 | $423.20 | 31.5% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 47 | 47 | $987.00 | $307.35 | 31.1% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 38 | 38 | $722.00 | $225.72 | 31.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 11 | 11 | $319.00 | $86.68 | 27.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 69 | 187 | $80,784 | $30,986 | 38.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 116 | 219 | $38,860 | $18,916 | 48.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 98 | 222 | $40,404 | $17,270 | 42.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 86 | 90 | $31,770 | $13,465 | 42.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 98 | 155 | $19,685 | $8,317 | 42.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 39 | 39 | $10,458 | $4,579 | 43.8% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 79 | 79 | $2,212 | $586.76 | 26.5% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 77 | 77 | $1,617 | $416.92 | 25.8% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2022 | 54 | 54 | $1,026 | $284.73 | 27.8% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 27 | 27 | $783.00 | $160.96 | 20.6% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 90 | 261 | $112,752 | $44,568 | 39.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 144 | 353 | $64,246 | $28,199 | 43.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 114 | 194 | $33,562 | $17,130 | 51.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 109 | 109 | $38,477 | $16,903 | 43.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 93 | 142 | $18,034 | $7,822 | 43.4% |
About Dr. Oluseun Medeyinlo, M.D
Dr. Oluseun Medeyinlo, M.D is a Critical Care Medicine healthcare provider based in Florence, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/10/2007. The National Provider Identifier (NPI) number assigned to this provider is 1205040136.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Oluseun Medeyinlo, M.D has received a total of $7,051 in payments from pharmaceutical and medical device companies, with $548.60 received in 2024. These payments were reported across 351 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($6,254).
As a Medicare-enrolled provider, Medeyinlo has provided services to 2,982 Medicare beneficiaries, totaling 4,976 services with total Medicare billing of $446,315. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease, Pulmonary Disease
- Location Florence, KY
- Active Since 05/10/2007
- Last Updated 09/13/2018
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1205040136
Products in Payments
- Spin (Device) $986.52
- TRELEGY ELLIPTA (Drug) $800.79
- NUCALA (Biological) $442.17
- OFEV (Drug) $373.37
- DUPIXENT (Biological) $318.90
- BREZTRI (Drug) $299.40
- ANORO (Drug) $233.54
- superDimension (Device) $219.12
- ACTHAR (Biological) $211.85
- SYMBICORT (Drug) $206.14
- GLASSIA (Biological) $187.16
- Yupelri (Drug) $180.55
- Prolastin-C Liquid (Biological) $156.05
- FASENRA (Drug) $139.63
- LONHALA MAGNAIR (Drug) $133.42
- LungGPS (Device) $123.72
- SPIRIVA RESPIMAT (Drug) $123.46
- OPSUMIT (Drug) $118.70
- AIRSUPRA (Drug) $107.71
- Calypso (Device) $91.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Florence
Ms. Lorie Loreman, Do, DO
Critical Care Medicine — Payments: $113,699
Irfan Budhani, Md, MD
Critical Care Medicine — Payments: $15,963
Mohamad Zein, Md, MD
Critical Care Medicine — Payments: $4,542
Dr. Latonya Brown, M.d, M.D
Critical Care Medicine — Payments: $3,975
Patricia Miles, M.d, M.D
Critical Care Medicine — Payments: $763.32
Brissa Westbrook, Np, NP
Critical Care Medicine — Payments: $621.93